Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study, Diabetes Care, vol.2, issue.2, pp.120-126, 1979. ,
DOI : 10.2337/diacare.2.2.120
Myocardial Structure, Function, and Scar in Patients With Type 1 Diabetes Mellitus, Circulation, vol.124, issue.16, pp.1241737-1746, 2011. ,
DOI : 10.1161/CIRCULATIONAHA.111.022327
Endothelial dysfunction in diabetes mellitus. Vasc Health Risk Manag, pp.853-876, 2007. ,
Diabetes Mellitus and Vascular Endothelial Dysfunction: Current Perspectives, Current Vascular Pharmacology, vol.10, issue.1, pp.19-32 ,
DOI : 10.2174/157016112798829797
Vascular Wall Renin-Angiotensin Pathway in Control of the Circulation, The American Journal of Medicine, vol.77, issue.4, pp.31-36, 1984. ,
DOI : 10.1016/S0002-9343(84)80035-2
Small artery structure in hypertension. Dual processes of remodeling and growth, Hypertension, vol.21, issue.4, pp.391-397, 1993. ,
DOI : 10.1161/01.HYP.21.4.391
The pathogenesis of atherosclerosis, N Engl J Med, issue.8, pp.314488-500, 1986. ,
Aldosterone and angiotensin: Role in diabetes and cardiovascular diseases, European Journal of Pharmacology, vol.697, issue.1-3, pp.1-31 ,
DOI : 10.1016/j.ejphar.2012.09.034
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, The Lancet, vol.359, issue.9311, pp.359995-1003, 2002. ,
DOI : 10.1016/S0140-6736(02)08089-3
Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The heart outcomes prevention evaluation study investigators, N Engl J Med, vol.342, issue.3, pp.145-153, 2000. ,
Behavioural and cardiovascular effects of disrupting the angiotensin II
type-2 receptor gene in mice, Nature, vol.377, issue.6551, pp.744-747, 1995. ,
DOI : 10.1038/377744a0
Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor, Proceedings of the National Academy of Sciences, vol.96, issue.11, pp.966506-6510, 1999. ,
DOI : 10.1073/pnas.96.11.6506
AT2 Receptor Stimulation Enhances Antihypertensive Effect of AT1 Receptor Antagonist in Hypertensive Rats, Hypertension, vol.34, issue.5, pp.1112-1116, 1999. ,
DOI : 10.1161/01.HYP.34.5.1112
Role of the angiotensin II AT2-subtype receptors in the blood pressure-lowering effect of losartan in salt-restricted rats, Journal of Hypertension, vol.16, issue.Supplement, pp.2039-2043, 1998. ,
DOI : 10.1097/00004872-199816121-00027
AT2 Receptor Stimulation Increases Aortic Cyclic GMP in SHRSP by a Kinin-Dependent Mechanism, Hypertension, vol.31, issue.1, pp.349-355, 1998. ,
DOI : 10.1161/01.HYP.31.1.349
Autoradiographic Identification of Kidney Angiotensin IV Binding Sites and Angiotensin IV-Induced Renal Cortical Blood Flow Changes in Rats, Peptides, vol.19, issue.2, pp.269-277, 1998. ,
DOI : 10.1016/S0196-9781(97)00291-X
Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow, Regulatory Peptides, vol.74, issue.2-3, pp.2-3185, 1998. ,
DOI : 10.1016/S0167-0115(98)00039-1
Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice, Cardiovascular Research, vol.77, issue.1, pp.178-187, 2008. ,
DOI : 10.1093/cvr/cvm021
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma, Atherosclerosis, vol.200, issue.1, pp.37-44, 2008. ,
DOI : 10.1016/j.atherosclerosis.2007.12.042
Vascular reactivity in mesenteric resistance arteries following chronic nitric oxide synthase inhibition in Wistar rats, British Journal of Pharmacology, vol.265, issue.Suppl??ment, pp.341-346, 1996. ,
DOI : 10.1111/j.1476-5381.1996.tb15196.x
Reactive Oxygen Species and Cyclooxygenase 2-Derived Thromboxane A2 Reduce Angiotensin II Type 2 Receptor Vasorelaxation in Diabetic Rat Resistance Arteries, Hypertension, vol.55, issue.2, pp.339-344, 2010. ,
DOI : 10.1161/HYPERTENSIONAHA.109.140236
Paradoxical effects of ethoxidine, a topoisomerase I inhibitor, in the cellular processes leading to angiogenesis on endothelial cells, Carcinogenesis, vol.32, issue.3, pp.286-295, 2011. ,
DOI : 10.1093/carcin/bgq260
Vascular smooth muscle cells exhibit increased growth in response to elevated glucose, Biochemical and Biophysical Research Communications, vol.187, issue.1, pp.552-560, 1992. ,
DOI : 10.1016/S0006-291X(05)81529-3
Alterations of rabbit aortic smooth muscle cell proliferation in diabetes mellitus, Cardiovascular Research, vol.27, issue.7, pp.1229-1232, 1993. ,
DOI : 10.1093/cvr/27.7.1229
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I, Circulation, vol.108, issue.12, pp.1527-1532, 2003. ,
DOI : 10.1161/01.CIR.0000091257.27563.32
Endothelial Function: Cardiac Events, Circulation, vol.111, issue.3, pp.363-368, 2005. ,
DOI : 10.1161/01.CIR.0000153339.27064.14
The clinical implications of endothelial dysfunction, Journal of the American College of Cardiology, vol.42, issue.7, pp.1149-1160, 2003. ,
DOI : 10.1016/S0735-1097(03)00994-X
Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition, Diabetes, issue.10, pp.431221-1228, 1994. ,
Pathogenesis, prevention, and treatment of diabetic nephropathy, The Lancet, vol.352, issue.9123, pp.213-219, 1998. ,
DOI : 10.1016/S0140-6736(98)01346-4
Cerebroprotective effect of angiotensin IV in experimental ischemic stroke in the rat mediated by AT(4) receptors, J Physiol Pharmacol, vol.57, issue.3, pp.329-342, 2006. ,
Stimulation of the AT2 receptor reduced atherogenesis in ApoEAT1A(-/-) double knock out mice, J Mol Cell Cardiol, vol.2012, issue.523, pp.630-637 ,
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes, Diabetologia, vol.355, issue.3, pp.584-592, 2010. ,
DOI : 10.1007/s00125-009-1619-x
Genetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure, J Biomed Biotechnol, 2011. ,
receptors: cardiovascular hope or hype?, British Journal of Pharmacology, vol.125, issue.5, pp.809-824, 2003. ,
DOI : 10.1038/sj.bjp.0705448
Henrion D: High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats, Circulation, issue.8, pp.1111006-1011, 2005. ,
Role of AT2 Receptors in Angiotensin II??Stimulated Contraction of Small Mesenteric Arteries in Young SHR, Hypertension, vol.33, issue.1, pp.366-372, 1999. ,
DOI : 10.1161/01.HYP.33.1.366
Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats, AJP: Renal Physiology, vol.300, issue.3, pp.700-706, 2011. ,
DOI : 10.1152/ajprenal.00616.2010
The potential role of the angiotensin subtype 2 receptor in cardiovascular protection, Current Hypertension Reports, vol.262, issue.4, pp.260-262, 2009. ,
DOI : 10.1007/s11906-009-0044-3
Emerging drugs which target the renin???angiotensin???aldosterone system, Expert Opinion on Emerging Drugs, vol.12, issue.4, pp.619-630, 2011. ,
DOI : 10.1126/science.1192152
Perspective: A tale of two receptors, Nature, vol.185, issue.7434, p.9 ,
DOI : 10.1038/493S9a
Non-peptide AT2-receptor agonists, Current Opinion in Pharmacology, vol.11, issue.2, pp.187-192, 2011. ,
DOI : 10.1016/j.coph.2010.11.002
Evidence That the Angiotensin IV (AT4) Receptor Is the Enzyme Insulin-regulated Aminopeptidase, Journal of Biological Chemistry, vol.276, issue.52, pp.27648623-48626, 2001. ,
DOI : 10.1074/jbc.C100512200
From angiotensin IV binding site to AT4 receptor, Molecular and Cellular Endocrinology, vol.302, issue.2, pp.159-166, 2009. ,
DOI : 10.1016/j.mce.2008.11.015
Alzheimer's, Angiotensin IV and an Aminopeptidase, Biological & Pharmaceutical Bulletin, vol.27, issue.6, pp.765-767, 2004. ,
DOI : 10.1248/bpb.27.765
Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers, British Journal of Pharmacology, vol.333, issue.1, pp.37-47, 2011. ,
DOI : 10.1111/j.1476-5381.2011.01402.x
Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors, Journal of Hypertension, vol.26, issue.10, pp.262008-2015, 2008. ,
DOI : 10.1097/HJH.0b013e32830dd5ee
URL : https://hal.archives-ouvertes.fr/hal-00594043
Insulin-Regulated Aminopeptidase Deficiency Provides Protection against Ischemic Stroke in Mice, Journal of Neurotrauma, vol.29, issue.6, pp.291243-1248 ,
DOI : 10.1089/neu.2011.1824